Literature DB >> 26030394

Putting evidence into practice: evidence-based interventions for oral agents for cancer.

Sandra L Spoelstra1, Holly Sansoucie2.   

Abstract

BACKGROUND: The limited evidence available suggests that adherence to oral agents for cancer is a significant clinical problem and may have a substantial impact on treatment success or failure. Adherence is a difficult issue among patients who are very sick with a life-threatening disease who often must adhere to complex treatment protocols independently at home.
OBJECTIVES: This article aims to identify effective interventions for the promotion, treatment, and management of adherence to oral agents for cancer and to synthesize the literature for use in clinical practice.
METHODS: As part of the Oncology Nursing Society (ONS) Putting Evidence Into Practice (PEP) initiative, a comprehensive examination of the current literature was conducted to identify effective interventions for patients prescribed oral agents for cancer. The ONS PEP weight-of-evidence classification schema levels of evidence were used to categorize interventions to assist nurses in identifying strategies that are effective at improving adherence.
FINDINGS: The majority of evidence found was conducted in conditions other than cancer; therefore, research is needed to identify whether these interventions are effective at promoting adherence in patients with cancer.

Entities:  

Keywords:  PEP; Putting Evidence Into Practice; adherence; interventions; oral agents for cancer

Mesh:

Substances:

Year:  2015        PMID: 26030394     DOI: 10.1188/15.S1.CJON.60-72

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  8 in total

1.  Patients' Perception of App-based Educational and Behavioural Interventions for Enhancing Oral Anticancer Medication Adherence.

Authors:  Eskinder Eshetu Ali; Jo Lene Leow; Lita Chew; Kevin Yi-Lwern Yap
Journal:  J Cancer Educ       Date:  2018-12       Impact factor: 2.037

2.  Interventions to Enhance Adherence to Oral Antineoplastic Agents: A Scoping Review.

Authors:  Shoshana M Rosenberg; Keith J Petrie; Annette L Stanton; Lan Ngo; Emma Finnerty; Ann H Partridge
Journal:  J Natl Cancer Inst       Date:  2020-05-01       Impact factor: 13.506

3.  Design Considerations in the Development of App-Based Oral Anticancer Medication Management Systems: a Qualitative Evaluation of Pharmacists' and Patients' Perspectives.

Authors:  Eskinder Eshetu Ali; Sharlene Si Ling Chan; Huan Yu Poh; Yosua Amadeus Susanto; Thendral Suganya; Jo Lene Leow; Chee Khiang Pang; Lita Chew; Kevin Yi-Lwern Yap
Journal:  J Med Syst       Date:  2019-02-06       Impact factor: 4.460

Review 4.  Investigation of Intervention Solutions to Enhance Adherence to Oral Anticancer Medicines in Adults: Overview of Reviews.

Authors:  Thu Ha Dang; Abdur Rahim Mohammad Forkan; Nilmini Wickramasinghe; Prem Prakash Jayaraman; Marliese Alexander; Kate Burbury; Penelope Schofield
Journal:  JMIR Cancer       Date:  2022-04-27

Review 5.  The Evolution of Gero-Oncology Nursing.

Authors:  Stewart M Bond; Ashley Leak Bryant; Martine Puts
Journal:  Semin Oncol Nurs       Date:  2015-11-17       Impact factor: 2.315

Review 6.  Optimizing Communication and Adherence to Iron Chelation Therapy From Diagnosis to Treatment in Patients With Myelodysplastic Syndromes.

Authors:  Jayshree Shah; Phyllis McKiernan
Journal:  J Adv Pract Oncol       Date:  2016-11-01

7.  User acceptance of an app-based adherence intervention: Perspectives from patients taking oral anticancer medications.

Authors:  Eskinder Eshetu Ali; Sharlene Si Ling Chan; Jo Lene Leow; Lita Chew; Kevin Yi-Lwern Yap
Journal:  J Oncol Pharm Pract       Date:  2018-05-23       Impact factor: 1.809

8.  Self-reported adherence to oral cancer therapy: relationships with symptom distress, depression, and personal characteristics.

Authors:  Donna L Berry; Traci M Blonquist; Fangxin Hong; Barbara Halpenny; Ann H Partridge
Journal:  Patient Prefer Adherence       Date:  2015-11-04       Impact factor: 2.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.